nference, Inc, based in Cambridge, MA, is dedicated to leveraging the exponential growth of biomedical data, particularly from electronic medical records (EMRs), to pioneer transformative technologies in healthcare. By collaborating with medical centers, nference transforms decades of intricate and mostly unstructured EMR data into robust solutions. These solutions empower scientists worldwide to innovate and create personalized diagnostics and treatments, ushering in the next generation of healthcare advancements.
The company was co-founded by Murali Aravamudan, CEO, and Venky Soundararajan, PhD, Chief Scientific Officer, with a leadership team composed of seasoned experts from various sectors including technology, life sciences, and data. nference has raised over $150 million in capital from notable investors like Matrix Capital Management, Matrix Partners, Mayo Clinic Ventures, and NTTVC, illustrating strong support for their mission and vision.
nference's commitment to curating and synthesizing the global biomedical data landscape to facilitate scientific breakthroughs underscores its belief in utilizing technology to enhance human health. With offices in Cambridge, MA, Bangalore, Toronto, and Rochester, nference's reach extends globally as it continues to drive innovation and collaboration in the healthcare industry.
Generated from the website content
